Tsimikas, S <br/><br/>
In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Mar 2000 
 - 689-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.20.3.689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antibody Specificity<br/>Aorta, Thoracic--metabolism<br/>Arteriosclerosis--diagnosis<br/>Cholesterol--blood<br/>Diet, Atherogenic<br/>Epitopes--metabolism<br/>Hyperlipidemias--diagnosis<br/>Iodine Radioisotopes--pharmacokinetics<br/>Lipoproteins, LDL--analysis<br/>Malondialdehyde--immunology<br/>Mice<br/>Mice, Knockout<br/>Organ Size<br/>Oxidation-Reduction<br/>Rabbits<br/>Receptors, LDL--genetics<br/>Staining and Labeling<br/>Triglycerides--blood<br/>Vitamin E--blood